GGrantIndex
← Leaderboards

Robert A Casero

Michigan State University

Google Scholar ↗PubMed ↗ORCID ↗
$11,306,418
Attributed
$15,535,488
Total exposure
8
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.2M · FY2005–25
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$15,535,488 · 8

By mechanism

R01$15,393,874 · 5
P50$131,614 · 2
R13$10,000 · 1

Top collaborators

Most similar at Michigan State University

Same institution · by research overlap

Others in their field

Top investigators on “Polyamines”

Research focus

PolyaminesAnalogDesignIn VivoIn VitroMalignant NeoplasmsResponsePathway InteractionsAffectColon CarcinomaBaseTumorigenesisNeoplastic CellPublishingMolecularEnzymesSpermidineTumorCellsToxic EffectGene MutationGenetic TranscriptionReactive Oxygen SpeciesHydrogen Peroxide

Grant awards (46)

Leveraging modulation of polyamine metabolism for therapeutic advantage in genetic disorders$671,409
R01 · FY2025 · HD
Leveraging modulation of polyamine metabolism for therapeutic advantage in genetic disorders$672,433
R01 · FY2024 · HD
Leveraging modulation of polyamine metabolism for therapeutic advantage in genetic disorders$716,202
R01 · FY2023 · HD
Self-immolative prodrug/miRNA nanoparticle combinations for cancer treatment$447,493
R01 · FY2023 · CA
Self-immolative prodrug/miRNA nanoparticle combinations for cancer treatment$447,493
R01 · FY2022 · CA
Self-immolative prodrug/miRNA nanoparticle combinations for cancer treatment$456,624
R01 · FY2021 · CA
Identification of novel spermine oxidase (SMOX) inhibitors as probes for an emerging chemoprevention target$607,409
R01 · FY2020 · CA · contact PI
Self-immolative prodrug/miRNA nanoparticle combinations for cancer treatment$456,624
R01 · FY2020 · CA
Identification of novel spermine oxidase (SMOX) inhibitors as probes for an emerging chemoprevention target$600,018
R01 · FY2019 · CA · contact PI
Self-immolative prodrug/miRNA nanoparticle combinations for cancer treatment$469,749
R01 · FY2019 · CA
Identification of novel spermine oxidase (SMOX) inhibitors as probes for an emerging chemoprevention target$99,506
R01 · FY2019 · CA · contact PI
Identification of novel spermine oxidase (SMOX) inhibitors as probes for an emerging chemoprevention target$630,557
R01 · FY2018 · CA · contact PI
Identification of novel spermine oxidase (SMOX) inhibitors as probes for an emerging chemoprevention target$102,584
R01 · FY2018 · CA · contact PI
Identification of novel spermine oxidase (SMOX) inhibitors as probes for an emerging chemoprevention target$640,484
R01 · FY2017 · CA · contact PI
Identification of novel spermine oxidase (SMOX) inhibitors as probes for an emerging chemoprevention target$94,709
R01 · FY2017 · CA · contact PI
Identification of novel spermine oxidase (SMOX) inhibitors as probes for an emerging chemoprevention target$658,164
R01 · FY2016 · CA · contact PI
Re-expression of Aberrantly Silenced Genes Induced by Polyamine Analogues$343,195
R01 · FY2013 · CA · contact PI
The Role of Polyamine Oxidase in Antitumor Drug Response$301,184
R01 · FY2013 · CA · contact PI
Re-expression of Aberrantly Silenced Genes Induced by Polyamine Analogues$365,101
R01 · FY2012 · CA · contact PI
The Role of Polyamine Oxidase in Antitumor Drug Response$320,408
R01 · FY2012 · CA · contact PI
Re-expression of Aberrantly Silenced Genes Induced by Polyamine Analogues$365,101
R01 · FY2011 · CA · contact PI
The Role of Polyamine Oxidase in Antitumor Drug Response$320,408
R01 · FY2011 · CA · contact PI
Re-expression of Aberrantly Silenced Genes Induced by Polyamine Analogues$376,393
R01 · FY2010 · CA · contact PI
The Role of Polyamine Oxidase in Antitumor Drug Response$330,317
R01 · FY2010 · CA · contact PI
Re-expression of Aberrantly Silenced Genes Induced by Polyamine Analogues$376,393
R01 · FY2009 · CA · contact PI
The Role of Polyamine Oxidase in Antitumor Drug Response$330,317
R01 · FY2009 · CA · contact PI
Spermine N1-Acetylase Induction in Lung Cancers$364,316
R01 · FY2007 · CA · contact PI
Spermine N1-Acetylase Induction in Lung Cancers$375,197
R01 · FY2006 · CA · contact PI
The role of polyamine oxidase in antitumor drug response$319,715
R01 · FY2006 · CA · contact PI
Spermine N1-Acetylase Induction in Lung Cancers$384,225
R01 · FY2005 · CA
The role of polyamine oxidase in antitumor drug response$327,409
R01 · FY2005 · CA
Spermine N1-Acetylase Induction in Lung Cancers$384,225
R01 · FY2004 · CA
The role of polyamine oxidase in antitumor drug response$327,409
R01 · FY2004 · CA
Spermine N1-Acetylase Induction in Lung Cancers$384,225
R01 · FY2003 · CA
The role of polyamine oxidase in antitumor drug response$327,409
R01 · FY2003 · CA
Gordon Research Conference of Polyamine$5,000
R13 · FY2003 · CA
SPERMIDINE N1-ACETYLASE INDUCTION IN LUNG CANCERS$342,567
R01 · FY2002 · CA
NOVEL POLYAMINE ANALOGUES FOR BREAST CANCER TREATMENT$0
P50 · FY2002 · CA
CLINICAL AND BIOCHEMICAL ASSESSMENT OF N1,N11-DIETHYLNORSPERMINE IN LUNG CANCER$0
P50 · FY2002 · CA
SPERMIDINE N1-ACETYLASE INDUCTION IN LUNG CANCERS$333,012
R01 · FY2001 · CA
Gordon Research Conference of Polyamine$5,000
R13 · FY2001 · CA
CLINICAL AND BIOCHEMICAL ASSESSMENT OF N1,N11-DIETHYLNORSPERMINE IN LUNG CANCER$0
P50 · FY2001 · CA
NOVEL POLYAMINE ANALOGUES FOR BREAST CANCER TREATMENT$0
P50 · FY2001 · CA
SPERMIDINE N1-ACETYLASE INDUCTION IN LUNG CANCERS$323,890
R01 · FY2000 · CA
CLINICAL AND BIOCHEMICAL ASSESSMENT OF N1,N11-DIETHYLNORSPERMINE IN LUNG CANCER$131,614
P50 · FY2000 · CA
NOVEL POLYAMINE ANALOGUES FOR BREAST CANCER TREATMENT$0
P50 · FY2000 · CA